Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
Int J Infect Dis
; 104: 108-110, 2021 Mar.
Article
em En
| MEDLINE
| ID: mdl-33352323
ABSTRACT
Existing literature highlights the fact that patients with COVID-19 exhibit alterations in the coagulation process and are associated with respiratory and cardiovascular diseases, including acute respiratory distress syndrome and acute cor pulmonale. In this report, we describe the effects of systemic thrombolysis on acute cor pulmonale in a patient suffering from COVID-19. We demonstrated that systemic thrombolysis successfully improved the hemodynamics of our patient and resulted in a prominent reduction in hypercapnia, alveolar dead space, and ventilatory ratio.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Síndrome do Desconforto Respiratório
/
Terapia Trombolítica
/
Ativador de Plasminogênio Tecidual
/
SARS-CoV-2
/
COVID-19
/
Insuficiência Cardíaca
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article